The Manchester Short Splint in the Rehabilitation of Zone II Flexor Tendon Repairs
Launched by MANCHESTER UNIVERSITY NHS FOUNDATION TRUST · Feb 20, 2019
Trial Information
Current as of April 25, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult male and female patients 16 years and over, undergoing surgical repair of zone II flexor tendon injury in a single digit
- Exclusion Criteria:
- • Adult patients lacking capacity or motivation to participate in the planned physiotherapy
- • Adult patients with special needs and vulnerable groups
- • Adult patients who undergo surgical repair of their flexor tendon more than 4 days after the initial injury
- • Patients unable to understand English adequately
- • Adult patients unable to attend the hospital facility for the requisite number of planned physiotherapy sessions (social reasons)
- • Adult patients with multiple level injuries
- • Injuries with soft tissue loss requiring coverage
- • Adult patients with two nerve injuries on the same finger
- • Adult patients with multiple digit flexor tendon injury
- • Adult patients with concomitant bony injury to the hand
- • Children under 16 years age
About Manchester University Nhs Foundation Trust
Manchester University NHS Foundation Trust is a leading healthcare organization dedicated to delivering exceptional patient care and advancing medical research. As an integral part of the UK's National Health Service, the Trust encompasses a range of hospitals and services, fostering innovation in clinical research and trials. With a strong emphasis on collaboration and excellence, Manchester University NHS Foundation Trust is committed to improving health outcomes through rigorous scientific investigation and the translation of research findings into practice, ensuring that patients benefit from the latest advancements in medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Manchester, , United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials